Cargando…

Serum Autoantibodies against STIP1 as a Potential Biomarker in the Diagnosis of Esophageal Squamous Cell Carcinoma

Esophageal squamous cell carcinoma (ESCC) remains one of the leading causes of cancer-related mortality around the world. The identification of novel serum biomarkers is required for early detection of ESCC. This study was designed to elucidate whether autoantibodies against STIP1 could be a diagnos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Yi-Wei, Liu, Can-Tong, Huang, Xin-Yi, Huang, Li-Sheng, Luo, Yu-Hao, Hong, Chao-Qun, Guo, Hai-Peng, Xu, Li-Yan, Peng, Yu-Hui, Li, En-Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5567451/ https://www.ncbi.nlm.nih.gov/pubmed/28852266 http://dx.doi.org/10.1155/2017/5384091

Ejemplares similares

Combined detection of serum Dickkopf‐1 and its autoantibodies to diagnose esophageal squamous cell carcinoma
por: Peng, Yu‐Hui, et al.
Publicado: (2016)

Autoantibodies as Potential Biomarkers for the Early Detection of Esophageal Squamous Cell Carcinoma
por: Xu, Yi-Wei, et al.
Publicado: (2014)

Combined detection of serum autoantibodies as diagnostic biomarkers in esophagogastric junction adenocarcinoma
por: Xu, Yi-Wei, et al.
Publicado: (2018)

Parkinson’s Disease-Specific Autoantibodies against the Neuroprotective Co-Chaperone STIP1
por: Tan, Jolene Su Yi, et al.
Publicado: (2022)

Diagnostic Value of Autoantibodies against Ezrin in Esophageal Squamous Cell Carcinoma
por: Li, Lan, et al.
Publicado: (2017)

Autoantibodies: Potential clinical applications in early detection of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma
por: Xu, Yi-Wei, et al.
Publicado: (2019)

Serum proteomic-based analysis identifying autoantibodies against PRDX2 and PRDX3 as potential diagnostic biomarkers in nasopharyngeal carcinoma
por: Lin, Lie-Hao, et al.
Publicado: (2017)

Autoantibodies against p53, MMP-7, and Hsp70 as Potential Biomarkers for Detection of Nonmelanoma Skin Cancers
por: Yang, Shi-Han, et al.
Publicado: (2021)

Serum insulin-like growth factor binding protein-3 as a potential biomarker for diagnosis and prognosis of oesophageal squamous cell carcinoma
por: Luo, Yun, et al.
Publicado: (2022)

Serum Insulin-Like Growth Factor Binding Protein 7 as a Potential Biomarker in the Diagnosis and Prognosis of Esophagogastric Junction Adenocarcinoma
por: Liu, Can-Tong, et al.
Publicado: (2020)

Identification of novel serum autoantibody biomarkers for early esophageal squamous cell carcinoma and high-grade intraepithelial neoplasia detection
por: Chen, Zhibin, et al.
Publicado: (2023)

Tumor Stress-Induced Phosphoprotein1 (STIP1) as a Prognostic Biomarker in Ovarian Cancer
por: Chao, Angel, et al.
Publicado: (2013)

Serum IGFBP-1 as a potential biomarker for diagnosis of early-stage upper gastrointestinal tumour
por: Xu, Yi-Wei, et al.
Publicado: (2020)

Anti-CXCL8 Autoantibody: A Potential Diagnostic Biomarker for Esophageal Squamous Cell Carcinoma
por: Chen, Huili, et al.
Publicado: (2022)

Prognostic relevance of Bmi-1 expression and autoantibodies in esophageal squamous cell carcinoma
por: Liu, Wan-li, et al.
Publicado: (2010)

A Panel of Tumor-associated Autoantibodies for the Detection of Early-stage Breast Cancer
por: Hong, Chao-Qun, et al.
Publicado: (2021)

Comparative proteomics identify HSP90A, STIP1 and TAGLN-2 in serum extracellular vesicles as potential circulating biomarkers for human adenomyosis
por: Chen, Dayong, et al.
Publicado: (2022)

GOLPH3 Promotes Cancer Growth by Interacting With STIP1 and Regulating Telomerase Activity in Pancreatic Ductal Adenocarcinoma
por: Wang, Kebing, et al.
Publicado: (2020)

Blood-based biomarkers for early detection of esophageal squamous cell carcinoma
por: Chu, Ling-Yu, et al.
Publicado: (2020)

Circulating Levels of L1-cell Adhesion Molecule as a Serum Biomarker for Early Detection of Gastric Cancer and Esophagogastric Junction Adenocarcinoma
por: Chu, Ling-Yu, et al.
Publicado: (2020)

Serum anti-SPP1 autoantibody as a potential novel biomarker in detection of esophageal squamous cell carcinoma
por: Wang, Chen, et al.
Publicado: (2022)

Combination of autoantibodies against NY-ESO-1 and viral capsid antigen immunoglobulin A for improved detection of nasopharyngeal carcinoma
por: PENG, YU-HUI, et al.
Publicado: (2014)

Blood-based Markers in the Prognostic Prediction of Esophagogastric Junction Cancer
por: Liu, Can-Tong, et al.
Publicado: (2020)

Intracellular targeting of STIP1 inhibits human cancer cell line growth
por: Lin, Chiao-Yun, et al.
Publicado: (2021)

Serum Metabolomics for Biomarker Screening of Esophageal Squamous Cell Carcinoma and Esophageal Squamous Dysplasia Using Gas Chromatography-Mass Spectrometry
por: Zhang, Su, et al.
Publicado: (2020)

Anti-CDC25B autoantibody predicts poor prognosis in patients with advanced esophageal squamous cell carcinoma
por: Dong, Jun, et al.
Publicado: (2010)

Serum STIP1, a Novel Indicator for Microvascular Invasion, Predicts Outcomes and Treatment Response in Hepatocellular Carcinoma
por: Ma, Xiao-Lu, et al.
Publicado: (2020)

The Diagnostic Value of Serum IGFBP7 in Patients with Esophageal Squamous Cell Carcinoma
por: Huang, Xinyi, et al.
Publicado: (2019)

Beyond COVID: Reframing the Global Problematique with STiP (Systems Thinking in Practice)
por: Ison, Raymond L.
Publicado: (2023)

JAK2-Mediated Phosphorylation of Stress-Induced Phosphoprotein-1 (STIP1) in Human Cells
por: Chao, Angel, et al.
Publicado: (2022)

Serum insulin-like growth factor binding protein 3 as a promising diagnostic and prognostic biomarker in esophagogastric junction adenocarcinoma
por: Ding, Tian-Yan, et al.
Publicado: (2022)

Serum DSG2 as a potential biomarker for diagnosis of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma
por: Liu, Yin-Qiao, et al.
Publicado: (2022)

Sputum Autoantibodies Are More Relevant in Autoimmune Responses in Asthma than Are Serum Autoantibodies
por: Qin, Rundong, et al.
Publicado: (2019)

Identification and Evaluation of Autoantibody to a Novel Tumor-Associated Antigen GNA11 as a Biomarker in Esophageal Squamous Cell Carcinoma
por: Wang, Huimin, et al.
Publicado: (2021)

RBBP7 is a prognostic biomarker in patients with esophageal squamous cell carcinoma
por: Yu, Ning, et al.
Publicado: (2018)

Serum Metabolomic Profiling Reveals Biomarkers for Early Detection and Prognosis of Esophageal Squamous Cell Carcinoma
por: Wang, Pan Pan, et al.
Publicado: (2022)

Anti-POSTN and Anti-TIMP1 Autoantibodies as Diagnostic Markers in Esophageal Squamous Cell Carcinoma
por: Xie, Weihong, et al.
Publicado: (2022)

Autoantibodies against tumor‐associated antigens combined with microRNAs in detecting esophageal squamous cell carcinoma
por: Sun, Guiying, et al.
Publicado: (2019)

Single nucleotide polymorphism rs13042395 in the SLC52A3 gene as a biomarker for regional lymph node metastasis and relapse-free survival of esophageal squamous cell carcinoma patients
por: Tan, Hua-Zhen, et al.
Publicado: (2016)

Exploration of Potential Roles of a New LOXL2 Splicing Variant Using Network Knowledge in Esophageal Squamous Cell Carcinoma
por: Wu, Bing-Li, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_pvphr3l46hc5nsjeq8nh823mf9